Vacuolar-ATPase inhibitors are antimicrobial agents active against intracellular mycobacteria
Publication Date
Publication Journal
Author(s)
Leah Rankine-Wilson, Tirosh Shapira, Jake Felker, Matthew Christofferson, Henok Sahile, Joseph Chao, Houria Afshar, Raymond J. Andersen, Jim Sun, and Yossef Av-Gay
Mycobacterium tuberculosis (Mtb) evades the host immune defenses by blocking phagosome acidification through its secreted phosphatase PtpA, which binds to the vacuolar ATPase (v-ATPase) and disrupts key cellular processes. This study examined the antimicrobial effects of three v-ATPase inhibitors on the growth of Mtb, M. abscessus, and M. bovis BCG. The findings revealed that the inhibitors alter host-bacteria interactions and that Bafilomycin A1 binds PtpA, highlighting new possibilities for developing host-targeted therapies against intracellular mycobacterial infections.